Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.200 | None | 0.947 | 6577 | 76 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.800 | None | 0.970 | 4395 | 24 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.600 | None | 0.972 | 4122 | 24 | 1987 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.700 | None | 0.976 | 4060 | 54 | 1989 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 1.000 | None | 0.967 | 3371 | 41 | 1983 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.966 | 3054 | 40 | 1986 | 2020 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.946 | 3042 | 25 | 1991 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.700 | None | 0.968 | 2998 | 43 | 1981 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.100 | None | 0.969 | 2979 | 38 | 1987 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.200 | None | 0.945 | 2946 | 20 | 1987 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.700 | None | 0.955 | 2682 | 104 | 1992 | 2020 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 2577 | 53 | 1997 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
disease | 0.900 | None | 0.981 | 2575 | 61 | 1987 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.100 | None | 0.967 | 2539 | 37 | 1986 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 1.000 | None | 0.979 | 2327 | 632 | 1989 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.500 | None | 0.958 | 1867 | 15 | 1989 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.200 | None | 0.957 | 1857 | 15 | 1991 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.982 | 1850 | 14 | 1990 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.500 | None | 0.944 | 1799 | 21 | 1984 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.100 | None | 0.962 | 1783 | 0 | 2003 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.800 | None | 0.983 | 1773 | 24 | 1982 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.400 | None | 0.968 | 1758 | 12 | 1992 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.983 | 1637 | 35 | 1986 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.200 | None | 0.976 | 1553 | 16 | 1997 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.600 | None | 0.983 | 1494 | 32 | 1988 | 2020 |